XML 23 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income $ 145,415 $ 1,150,648
Adjustments for:    
Depreciation and amortization 1,256,587 1,100,838
Expected credit losses 4,959 13,258
Share of loss of equity-accounted investees (14,794) (10,556)
Gain on sales of assets (13,261) (8,880)
Tax expense (58,806) 279,954
Net finance expense 1,009,781 567,950
Share-based compensation 25,762 14,116
Provisions for legal proceedings 72,988 15,565
Impairment of property, plant and equipment 22,624 13,613
Net realizable value inventory adjustments 31,995 20,419
DOJ (Department of Justice) and antitrust agreements 157,375 133,638
Fair value adjustment of biological assets 71,538 (86,487)
Provision for avian influenza 0 5,612
Net income and adjustments 2,712,163 3,209,688
Changes in assets and liabilities:    
Trade accounts receivable 683,555 160,085
Inventories (824,622) (955,245)
Recoverable taxes (19,460) 93,786
Other current and non-current assets (88,222) (362,166)
Biological assets (415,776) (398,066)
Trade accounts payable and supply chain finance (437,706) (575,413)
Taxes paid in installments (23,039) (51,896)
Other current and non-current liabilities (294,141) 179,416
DOJ and Antitrust agreements payment/reimbursement (98,767) (261,212)
Income taxes paid (400,299) (550,897)
Changes in operating assets and liabilities (1,918,477) (2,721,608)
Cash from operating activities 793,686 488,080
Interest paid (810,814) (604,927)
Interest received 79,886 73,699
Net cash flows used in operating activities 62,758 (43,148)
Cash flow from investing activities    
Purchases of property, plant and equipment (1,178,902) (714,122)
Dividends received 229 4,124
Purchase and disposals of intangible assets (7,194) (2,554)
Additions (disposals) to investments in joint ventures 26,352 (165,271)
Related party transactions (16,750) 4,650
Proceeds from sale of property, plant and equipment 48,109 35,615
Cash used in investing activities (1,128,156) (837,558)
Cash flow from financing activities    
Proceeds from loans and financings 3,865,514 4,494,204
Payments of loans and financings (2,700,661) (4,676,359)
Derivatives instruments received (settled) (6,483) (52,863)
Margin cash (35,429) (44,400)
Dividends paid (1,039,099) (1,573,855)
Dividends paid to non-controlling interest (2,920) (266,417)
Disposal of treasury shares 1,234 0
Payments of leasing contracts (220,810) (215,060)
Others (2,768) 0
Cash used in financing activities (141,422) (2,334,750)
Effect of exchange rate changes on cash and cash equivalents 110,804 120,535
Net change in cash and cash equivalents (1,096,016) (3,094,921)
Cash and cash equivalents beginning of period 4,565,136 5,613,672
Cash and cash equivalents at the end of period 3,469,120 2,518,751
Non-cash additions to right of use assets and lease liabilities 206,473 153,798
Capitalized interests 24,046 $ 17,374
Closing of the bargaining gain calculation $ (51,504)